Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Dai, MingRuia | Feng, XueJiana | Mo, ZengShuoa | Sun, Yaoa | Fu, Lub | Zhang, Yonga; c | Wu, Jiaxina; c | Yu, Bina; c | Zhang, Haihonga; c | Yu, Xianghuia; c | Wu, Huia; c; * | Kong, Weia; c; *
Affiliations: [a] National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China | [b] Laboratory of Pathogenic Microbiology and Immunology, College of Life science, Jilin Agricultural University, Changchun, China | [c] Key Laboratory for Molecular Enzymology and Engineering, the Ministry of Education, School of Life Sciences, Jilin University, Changchun, China
Correspondence: [*] Correspondence to: Hui Wu, and Wei Kong, School of Life Sciences, Jilin University, No. 2699 Qianjin Street, Changchun 130012, PR China. Tel.: 0431-85167795 (Hui Wu), 0431-85167790 (Wei Kong); E-mails: [email protected] (Hui Wu), [email protected] (Wei Kong).
Abstract: Background:Adjuvants are important components of vaccines and effectively enhance the immune response of specific antigens. However, the role of adjuvants or combinations of adjuvants in stimulating immunogenicity of the amyloid-β (Aβ) vaccine, as well as molecular mechanisms underlying such stimulation still remain unclear. A previous study of ours developed a norovirus P particle-based active Aβ epitope vaccine, PP-3copy-Aβ1-6-loop123, which stimulates a high titer of Aβ-specific antibodies in mouse Alzheimer’s disease (AD) models. Objective:The most effective and safe adjuvant that maximizes the immunogenicity of our protein vaccine was determined. Methods:We investigated four adjuvants (CpG, AS02, AS03, and MF59), and combinations of those, for capacity to enhance immunogenicity, and performed transcriptome analysis to explore mechanisms underlying the role of these in AD immunotherapy. Results:Addition of the adjuvant, AS02, remarkably improved the immunogenicity of the PP-3copy-Aβ1-6-loop123 vaccine without triggering an Aβ-specific T-cell response. Combinations of adjuvants, particularly CpG + AS02 and CpG + AS03, elicited a significantly elevated and prolonged Aβ-specific antibody response. Gene ontology and Kyoto Encyclopedia of Genes and Genomes analyses indicated that a combination of two adjuvants was more effective in activating immune-related pathways, thereby enhancing the immunogenicity of PP-3copy-Aβ1-6-loop123. Conclusion:These findings demonstrated that adjuvants can be used as enhancers in AD protein vaccination, and that a combination of CpG and AS-related adjuvants may be a very effective adjuvant candidate suitable for further clinical trials of the PP-3copy-Aβ1-6-loop123 vaccine. Our studies also revealed potential mechanisms underlying the stimulation of immune response of protein vaccines by adjuvants.
Keywords: Adjuvant, Alzheimer’s disease, amyloid-β, immunogenicity, mechanisms, vaccine
DOI: 10.3233/JAD-200351
Journal: Journal of Alzheimer's Disease, vol. 77, no. 4, pp. 1717-1732, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]